Although the underlying mechanism by which MMP-10 promotes RCC progression was not investigated in that study, the potential activation of EGFR and its downstream signaling as identified in the present study could well explain for its disadvantageous action of MMP-10 in RCC. Here, EGFR is linked to renal cell carcinoma.